Author
Listed:
- Kiyomitsu Miyachi
(Tsurumi West Menopause and Rheumatology Clinic, Japan)
- Kayoko Yamamoto
(Yokohama Soei University, Faculty of Nursing, Japan)
- Belinda Sasse
(MonashHealth, Department of Oncology, Australia)
- Kazuhito Murata
(Health Sciences Research Institute, First Diagnostic Division, Japan)
- Akiko Ihara
(Keigu Clinic, Diabetes and Women’s Health, Japan)
- Takao Koyama
(Koyama Takao Clinic, Japan)
Abstract
Aim: Postmenopausal women often contract the common cold. Following treatment with HRT, symptoms resolve in some women. We hypothesize menopausal hormone therapy (MHT) may increase anti-SARS-Cov-2 IgG antibody titers, leading to greater resilience against COVID-19 infection. Methods: 219 patients were enrolled. Anti-SARS-Cov-2 IgG antibody titers were measured, and the number of days since the second SARS-Cov-2 vaccination was recorded. Linear regression analysis was performed to examine the relationship between these two variables for patients receiving MHT, patients with rheumatoid arthritis (RA) receiving methotrexate and non-MHT/non-RA (NMR). Analysis was further divided into groups aged 60. Results: Anti-SARS-Cov-2 IgG antibody titers in the MHT group were significantly higher than NMR aged >50 (p 60 (p 50. This may confer additional protection against SARS-Cov-2 infection. Women with RA on methotrexate over 60 have lower antibody titers than NMR aged >60.
Suggested Citation
Kiyomitsu Miyachi & Kayoko Yamamoto & Belinda Sasse & Kazuhito Murata & Akiko Ihara & Takao Koyama, 2024.
"Impact of Menopausal Hormonal Therapy on Anti-SARS-Cov-2 Antibody Titers in Middle-Aged Women,"
European Journal of Clinical Medicine, European Open Science, vol. 5(2), pages 1-7, March.
Handle:
RePEc:epw:clinic:v:5:y:2024:i:2:id:12332
DOI: 10.24018/clinicmed.2024.5.2.332
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:epw:clinic:v:5:y:2024:i:2:id:12332. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Support Team (email available below). General contact details of provider: https://eu-opensci.org/index.php/clinicmed .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.